Details of the Drug Formulations

General Information of Drug (ID: DMH7IDQ)

• Drug Name: Dichlorphenamide Drug Info
• Synonyms: dichlorphenamide; Diclofenamide; 120-97-8; 4,5-dichlorobenzene-1,3-disulfonamide; Dichlofenamide; Dichlorophenamide; Daranide; Dichlorphenamid; Glauconide; Antidrasi; Glaucol; Oratrol; Diclofenamidum; Diclofenamida; Diclofenamid; Barastonin; Glaumid; Glafco; Glajust; 4,5-Dichloro-m-benzenedisulfonamide; 1,3-Benzenedisulfonamide, 4,5-dichloro-; Diclofenamidum [INN-Latin]; 4,5-Dichloro-1,3-disulfamoylbenzene; 1,3-Disulfamoyl-4,5-dichlorobenzene; Diclofenamida [INN-Spanish]; 1,3-Disulfamyl-4,5-dichlorobenzene; Dasanide; Keveyis; Antidrasi; Dichlorphenamide [BAN]; Llorens Brand of Dichlorphenamide; Merck Brand of Dichlorphenamide; CB 8000; I7A; Daranide (TN); Dichlorophenamide (DCP); Dichlorphenamide (USP); Diclofenamide (JP15/INN); 3,4-Dichloro-5-sulfamylbenzenesulfonamide; 4,5-Dichloro-1,3-benzenedisulfonamide; 4,5-Dichloro-benzene-1,3-disulfonic acid diamide; 4,5-DICHLOROBENZENE-1,3-DISULFONAMIDE

Indication

Disease Entry	ICD 11	Status	REF
Chronic glaucoma	9C61.0Z	Approved	[1]

• Therapeutic Class: Antiglaucomic Agents
• Cross-matching ID:
  PubChem CID: 3038
  ChEBI ID: CHEBI:101085
  CAS Number: 120-97-8
  TTD ID: D0J4GO
  ACDINA ID: D00191

Full List of Drug Formulations Containing This Drug

Dichlorphenamide 50 mg tablet

Company	Formulation ID	FDA Description
Taro Pharmaceuticals USA	F05690	Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Aluminum oxide
Strongbridge US; Taro Pharmaceuticals USA	F05691	Lactose monohydrate; Magnesium stearate; Starch, corn

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6807).